Page 146 - Read Online

Zhu et al. Function of Mcl-1 and its regulative relations with HCC

35. Fleischer B, Schulze-Bergkamen H, Schuchmann M, Weber A, resistance in hepatocellular carcinoma cells under hypoxia. Biomed
Biesterfeld S, Muller M, Krammer PH, Galle PR. Mcl-1 is an anti- Pharmacother 2017;88:342-8.
apoptotic factor for human hepatocellular carcinoma. Int J Oncol 53. Vickers ER, Kasza A, Kurnaz IA, Seifert A, Zeef LA, O’Donnell A,
2006;28:25-32. Hayes A, Sharrocks AD. Ternary complex factor-serum response
36. Henson ES, Hu X, Gibson SB. Herceptin sensitizes ErbB2- factor complex-regulated gene activity is required for cellular
overexpressing cells to apoptosis by reducing antiapoptotic Mcl-1 proliferation and inhibition of apoptotic cell death. Mol Cell Biol
expression. Clin Cancer Res 2006;12:845-53. 2004;24:10340-51.
37. Song L, Coppola D, Livingston S, Cress D, Haura EB. Mcl-1 regulates 54. Chuang WL, Lin PY, Lin HC, Chen YL. The apoptotic effect of
survival and sensitivity to diverse apoptotic stimuli in human non- ursolic acid on SK-Hep-1 cells is regulated by the PI3K/Akt, p38 and
small cell lung cancer cells. Cancer Biol Ther 2005;4:267-76. JNK MAPK signaling pathways. Molecules 2016;21:460.
38. Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL, 55. Yu Q, Liu ZY, Chen Q, Lin JS. Mcl-1 as a potential therapeutic target
Bataille R, Amiot M. Antisense strategy shows that Mcl-1 rather than for human hepatocelluar carcinoma. J Huazhong Univ Sci Technolog
Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma Med Sci 2016;36:494-500.
cells. Blood 2002;100:194-9. 56. Chang J, Liu Y, Zhang DD, Zhang DJ, Wu CT, Wang LS, Cui CP.
39. Le Gouill S, Podar K, Harousseau JL, Anderson KC. Mcl-1 regulation Hepatopoietin Cn suppresses apoptosis of human hepatocellular
and its role in multiple myeloma. Cell Cycle 2004;3:1259-62. carcinoma cells by up-regulating myeloid cell leukemia-1. World J
40. Ding Q, He X, Xia W, Hsu JM, Chen CT, Li LY, Lee DF, Yang JY, Gastroenterol 2010;16:193-200.
Xie X, Liu JC, Hung MC. Myeloid cell leukemia-1 inversely correlates 57. Gao M, Kong Q, Hua H, Yin Y, Wang J, Luo T, Jiang Y. AMPK-
with glycogen synthase kinase-3beta activity and associates with poor mediated up-regulation of mTORC2 and MCL-1 compromises the
prognosis in human breast cancer. Cancer Res 2007;67:4564-71. anti-cancer effects of aspirin. Oncotarget 2016;7:16349-61.
41. Glaser SP, Lee EF, Trounson E, Bouillet P, Wei A, Fairlie WD, 58. Zhang CZ, Chen GG, Merchant JL, Lai PB. Interaction between
Izon DJ, Zuber J, Rappaport AR, Herold MJ, Alexander WS, Lowe ZBP-89 and p53 mutants and its contribution to effects of HDACi on
SW, Robb L, Strasser A. Anti-apoptotic Mcl-1 is essential for the hepatocellular carcinoma. Cell Cycle 2012;11:322-34.
development and sustained growth of acute myeloid leukemia. Genes 59. Leu JI, Dumont P, Hafey M, Murphy ME, George DL. Mitochondrial
Dev 2012;26:120-5. p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat
42. Xiang Z, Luo H, Payton JE, Cain J, Ley TJ, Opferman JT, Tomasson Cell Biol 2004;6:443-50.
MH. Mcl1 haploinsufficiency protects mice from Myc-induced acute 60. Lin HH, Feng WC, Lu LC, Shao YY, Hsu CH, Cheng AL. Inhibition
myeloid leukemia. J Clin Invest 2010;120:2109-18. of the Wnt/beta-catenin signaling pathway improves the anti-tumor
43. Campbell KJ, Bath ML, Turner ML, Vandenberg CJ, Bouillet P, effects of sorafenib against hepatocellular carcinoma. Cancer Lett
Metcalf D, Scott CL, Cory S. Elevated Mcl-1 perturbs lymphopoiesis, 2016;381:58-66.
promotes transformation of hematopoietic stem/progenitor cells, and 61. Yang L, Perez AA, Fujie S, Warden C, Li J, Wang Y, Yung B, Chen
enhances drug resistance. Blood 2010;116:3197-207. YR, Liu X, Zhang H, Zheng S, Liu Z, Ann D, Yen Y. Wnt modulates
44. Weber A, Boger R, Vick B, Urbanik T, Haybaeck J, Zoller S, Teufel A, MCL1 to control cell survival in triple negative breast cancer. BMC
Krammer PH, Opferman JT, Galle PR, Schuchmann M, Heikenwalder Cancer 2014;14:124.
M, Schulze-Bergkamen H. Hepatocyte-specific deletion of the 62. Iqbal S, Zhang S, Driss A, Liu ZR, Kim HR, Wang Y, Ritenour C,
antiapoptotic protein myeloid cell leukemia-1 triggers proliferation Zhau HE, Kucuk O, Chung LW, Wu D. PDGF upregulates Mcl-
and hepatocarcinogenesis in mice. Hepatology 2010;51:1226-36. 1 through activation of beta-catenin and HIF-1alpha-dependent
45. Gruber S, Straub BK, Ackermann PJ, Wunderlich CM, Mauer J, signaling in human prostate cancer cells. PLoS One 2012;7:e30764.
Seeger JM, Buning H, Heukamp L, Kashkar H, Schirmacher P, 63. Kunnimalaiyaan S, Sokolowski KM, Balamurugan M, Gamblin
Bruning JC, Wunderlich FT. Obesity promotes liver carcinogenesis TC, Kunnimalaiyaan M. Xanthohumol inhibits Notch signaling
via Mcl-1 stabilization independent of IL-6Ralpha signaling. Cell Rep and induces apoptosis in hepatocellular carcinoma. PLoS One
2013;4:669-80. 2015;10:e0127464.
46. Al Zaid Siddiquee K, Turkson J. STAT3 as a target for inducing 64. Mott JL, Kobayashi S, Bronk SF, Gores GJ. mir-29 regulates Mcl-1
apoptosis in solid and hematological tumors. Cell Res 2008;18:254-67. protein expression and apoptosis. Oncogene 2007;26:6133-40.
47. Chen KF, Tai WT, Liu TH, Huang HP, Lin YC, Shiau CW, Li PK, 65. Xiong Y, Fang JH, Yun JP, Yang J, Zhang Y, Jia WH, Zhuang SM.
Chen PJ, Cheng AL. Sorafenib overcomes TRAIL resistance of Effects of microRNA-29 on apoptosis, tumorigenicity, and prognosis
hepatocellular carcinoma cells through the inhibition of STAT3. Clin of hepatocellular carcinoma. Hepatology 2010;51:836-845.
Cancer Res 2010;16:5189-99. 66. Kim DH, Sarbassov DD, Ali SM, King JE, Latek RR, Erdjument-
48. Wang JM, Lai MZ, Yang-Yen HF. Interleukin-3 stimulation of mcl-1 Bromage H, Tempst P, Sabatini DM. mTOR interacts with raptor
gene transcription involves activation of the PU.1 transcription factor to form a nutrient-sensitive complex that signals to the cell growth
through a p38 mitogen-activated protein kinase-dependent pathway. machinery. Cell 2002;110:163-75.
Mol Cell Biol 2003;23:1896-909. 67. Mills JR, Hippo Y, Robert F, Chen SM, Malina A, Lin CJ, Trojahn
49. Wang JM, Chao JR, Chen W, Kuo ML, Yen JJ, Yang-Yen HF. The U, Wendel HG, Charest A, Bronson RT, Kogan SC, Nadon R,
antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol Housman DE, Lowe SW, Pelletier J. mTORC1 promotes survival
3-kinase/Akt signaling pathway through a transcription factor through translational control of Mcl-1. Proc Natl Acad Sci U S A
complex containing CREB. Mol Cell Biol 1999;19:6195-206. 2008;105:10853-8.
50. Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 68. Bhat M, Yanagiya A, Graber T, Razumilava N, Bronk S, Zammit
2003;3:721-32. D, Zhao Y, Zakaria C, Metrakos P, Pollak M, Sonenberg N, Gores
51. Piret JP, Minet E, Cosse JP, Ninane N, Debacq C, Raes M, Michiels G, Jaramillo M, Morita M, Alain T. Metformin requires 4E-BPs to
C. Hypoxia-inducible factor-1-dependent overexpression of myeloid induce apoptosis and repress translation of Mcl-1 in hepatocellular
cell factor-1 protects hypoxic cells against tert-butyl hydroperoxide- carcinoma cells. Oncotarget 2016; doi: 10.18632/oncotarget.10671.
induced apoptosis. J Biol Chem 2005;280:9336-44. 69. Ding Q, Huo L, Yang JY, Xia W, Wei Y, Liao Y, Chang CJ, Yang
52. Liu Y, Gao F, Song W. Periostin contributes to arsenic trioxide Y, Lai CC, Lee DF, Yen CJ, Chen YJ, Hsu JM, Kuo HP, Lin CY,
138 Hepatoma Research ¦ Volume 3 ¦ July 06, 2017